drugset / Trial / NCT01134237
Intrapleural Urokinase for Retained Hemothorax
RandomizedParallel-groupTriple-blindTreatment
Summary
Intrapleural thrombolytic treatment with urokinase for retained hemothorax is effective and safe. However, previous study was limited in prospective observation study without control group.
Timeline
- Start
- 2010-05
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Urokinase | Protein / enzyme biologic | 100000 iu | Other |